Life Science Company News

Results 281 - 300 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25 »

Inventiva reports its 2022 full-year results

Read more ››
By: GlobenewsWire - 29 Mar 2023

Dyadic Reports 2022 Year End Results and Recent Company Progress

Read more ››
By: GlobenewsWire - 29 Mar 2023

Alpha Tau Medical to Present at Jefferies Radiopharma Innovation Summit

Read more ››
By: GlobenewsWire - 29 Mar 2023

Avadel Pharmaceuticals Enters into Royalty Agreement with RTW Investments for up to $75 Million

Read more ››
By: GlobenewsWire - 29 Mar 2023

Akero Therapeutics Announces Positive End-of-Phase 2 Meeting with the FDA and SYNCHRONY Phase 3 Program for Efruxifermin in NASH

Read more ››
By: GlobenewsWire - 29 Mar 2023

Oncocyte Announces Date Change for Fourth Quarter and Full Year 2022 Earnings Call

Read more ››
By: GlobenewsWire - 29 Mar 2023

Journey Medical Corporation Reports Full-Year 2022 Financial Results and Recent Corporate Highlights

Read more ››
By: GlobenewsWire - 29 Mar 2023

BioCryst Celebrates Bob Ingram’s Contributions to the Company’s Success

Read more ››
By: GlobenewsWire - 29 Mar 2023

US healthcare executive Dr. Ninfa Saunders, DHA, MVA, MSN, FACHE and other Board members to be nominated at general meeting; Chris Lindop not standing for re-election.

Read more ››
By: GlobenewsWire - 29 Mar 2023

Aligos Therapeutics Presents Clinical Data from NASH Program at the 2023 Paris Hepatology Conference

Read more ››
By: GlobenewsWire - 29 Mar 2023

Bolt Biotherapeutics Announces Positive Topline Data from BDC-1001 Phase 1 Dose-Escalation Trial in HER2-Expressing Tumors, Supporting Advancement to Phase 2 Clinical Studies

Read more ››
By: GlobenewsWire - 29 Mar 2023

IntelGenx Reports Fourth Quarter and Full-Year 2022 Financial Results

Read more ››
By: GlobenewsWire - 29 Mar 2023

Goodness Growth Holdings Reschedules Release of Fourth Quarter and Full Year 2022 Results to March 31, 2023

Read more ››
By: GlobenewsWire - 29 Mar 2023

Gradalis to Participate in the Cantor Fitzgerald Future of Oncology Symposium

Read more ››
By: GlobenewsWire - 29 Mar 2023

Atreca Reports Fourth Quarter and Full-Year 2022 Financial Results and ATRC-101 Data Update

Read more ››
By: GlobenewsWire - 29 Mar 2023

Lyra Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Read more ››
By: GlobenewsWire - 29 Mar 2023

Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab

Read more ››
By: GlobenewsWire - 29 Mar 2023

Avadel Pharmaceuticals Announces Proposed Underwritten Public Offering of ADSs and Series B Preferred Shares

Read more ››
By: GlobenewsWire - 29 Mar 2023

OpGen Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Read more ››
By: GlobenewsWire - 29 Mar 2023

Bolt Biotherapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Read more ››
By: GlobenewsWire - 29 Mar 2023
Results 281 - 300 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate